These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23704698)

  • 1. Glucuronidation of a sarpogrelate active metabolite is mediated by UDP-glucuronosyltransferases 1A4, 1A9, and 2B4.
    Kim HJ; Jeong ES; Seo KA; Shin KJ; Choi YJ; Lee SJ; Ghim JL; Sohn DR; Shin JG; Kim DH
    Drug Metab Dispos; 2013 Aug; 41(8):1529-37. PubMed ID: 23704698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of 1'- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7.
    Seo KA; Bae SK; Choi YK; Choi CS; Liu KH; Shin JG
    Drug Metab Dispos; 2010 Nov; 38(11):2007-13. PubMed ID: 20713656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
    Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
    Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regio- and isoform-specific glucuronidation of psoralidin: evaluation of 3-o-glucuronidation as a functional marker for UGT1A9.
    Sun H; Ma Z; Lu D; Wu B
    J Pharm Sci; 2015 Jul; 104(7):2369-77. PubMed ID: 25941108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of oxymetazoline glucuronidation in human liver microsomes: evidence for the involvement of UGT1A9.
    Mahajan MK; Uttamsingh V; Gan LS; Leduc B; Williams DA
    J Pharm Sci; 2011 Feb; 100(2):784-93. PubMed ID: 20669329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro glucuronidation of the primary metabolite of 10-chloromethyl-11-demethyl-12-oxo-calanolide A by human liver microsomes and its interactions with UDP-glucuronosyltransferase substrates.
    Liu X; Sheng L; Zhao M; Mi J; Liu Z; Li Y
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):89-96. PubMed ID: 25760535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4.
    Kaku T; Ogura K; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
    Biochem Pharmacol; 2004 Jun; 67(11):2093-102. PubMed ID: 15135306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 1'-hydroxymidazolam glucuronidation in human liver microsomes.
    Zhu B; Bush D; Doss GA; Vincent S; Franklin RB; Xu S
    Drug Metab Dispos; 2008 Feb; 36(2):331-8. PubMed ID: 17998299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quaternary ammonium-linked glucuronidation of trans-4-hydroxytamoxifen, an active metabolite of tamoxifen, by human liver microsomes and UDP-glucuronosyltransferase 1A4.
    Ogura K; Ishikawa Y; Kaku T; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
    Biochem Pharmacol; 2006 Apr; 71(9):1358-69. PubMed ID: 16480962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective glucuronidation of ornidazole in humans: predominant contribution of UDP-glucuronosyltransferases 1A9 and 2B7.
    Du J; You T; Chen X; Zhong D
    Drug Metab Dispos; 2013 Jul; 41(7):1306-18. PubMed ID: 23571427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic UDP-glucuronosyltransferase is responsible for eslicarbazepine glucuronidation.
    Loureiro AI; Fernandes-Lopes C; Bonifácio MJ; Wright LC; Soares-da-Silva P
    Drug Metab Dispos; 2011 Sep; 39(9):1486-94. PubMed ID: 21673130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes.
    Kuehl GE; Bigler J; Potter JD; Lampe JW
    Drug Metab Dispos; 2006 Feb; 34(2):199-202. PubMed ID: 16258079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases.
    Tong Z; Li H; Goljer I; McConnell O; Chandrasekaran A
    Drug Metab Dispos; 2007 Dec; 35(12):2203-10. PubMed ID: 17875670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-glucuronidation of nicotine and cotinine in human: formation of cotinine glucuronide in liver microsomes and lack of catalysis by 10 examined UDP-glucuronosyltransferases.
    Ghosheh O; Hawes EM
    Drug Metab Dispos; 2002 Sep; 30(9):991-6. PubMed ID: 12167564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfinpyrazone C-glucuronidation is catalyzed selectively by human UDP-glucuronosyltransferase 1A9.
    Kerdpin O; Elliot DJ; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2006 Dec; 34(12):1950-3. PubMed ID: 16985098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of human uridine diphosphate-glucuronosyltransferase isoforms responsible for the glucuronidation of 10,11-dihydro-10-hydroxy-carbazepine.
    Huang K; Que L; Ding Y; Chu N; Qian Z; Qin W; Chen Y; Zhang J; He Q
    J Pharm Pharmacol; 2021 Mar; 73(3):388-397. PubMed ID: 33793880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of human UDP-glucuronyltransferases on the formation of the methylenedioxymethamphetamine (ecstasy) phase II metabolites R- and S-3-methoxymethamphetamine 4-O-glucuronides.
    Schwaninger AE; Meyer MR; Zapp J; Maurer HH
    Drug Metab Dispos; 2009 Nov; 37(11):2212-20. PubMed ID: 19666989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.